Adipose tissue macrophage-derived exosomal miR-29a regulates obesity-associated insulin resistance
Retatrutide, with triple-target effects (it works at the two receptors mentioned above and the glucagon receptor), caused people to lose about a quarter of their body weight after a year in a Phase II study (Jastreboff AM et al, N Engl J Med 2023;389(6):514526), although a follow-up study found the weight loss more in line with tirzepatide
Results GHK-Cu administration alleviated CS-induced emphysematous changes We assessed the efficacy of GHK-Cu administration in CS-induced emphysema
How much will my treatment cost
Whether that has to do with resolvins that are produced
GLP-1 receptor agonists may be linked to an increased risk of hair loss (alopecia), and although the absolute risk is low, researchers want to understand how the occurrence of this adverse effect compares to other commonly prescribed diabetes drugs, hoping to better inform treatment decisions for practitioners and patients